NCT05184842 Metabolically Optimized, Non-cytotoxic Low Dose Weekly Decitabine/Venetoclax in MDS and AML Status RECRUITING Phase PHASE2
NCT05183035 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML) Status RECRUITING Phase PHASE3
NCT05170828 Cryopreserved MMUD BM With PTCy for Hematologic Malignancies Status WITHDRAWN Phase PHASE1
NCT05155709 A Study of Siremadlin in Combination With Venetoclax Plus Azacitidine in Adult Participants With Acute Myeloid Leukemia (AML) Who Are Ineligible for Chemotherapy. Status COMPLETED Phase PHASE1
NCT05153330 Study of BMF-219, a Covalent Menin Inhibitor, in Adult Patients With AML, ALL (With KMT2A/ MLL1r, NPM1 Mutations), DLBCL, MM, and CLL/SLL Status TERMINATED Phase PHASE1
NCT05150561 Muscle Dysfunction in Patients With Haematological Diseases Status ACTIVE_NOT_RECRUITING Phase N/A
NCT05149339 Vitamin D Effect on A Disintegrin-like And Metalloprotease Thrombospondin1 Motif 13& Interleukin 6 in Leukemia Status COMPLETED Phase PHASE1/PHASE2
NCT05144334 A Study of BTX-1188 in Subjects With Advanced Malignancies Status TERMINATED Phase PHASE1
NCT05140811 A Study of IMM01 Combined With Azacitidine in Patients With Acute Myeloid Leukemia and Myelodysplastic Syndrome Status UNKNOWN Phase PHASE1/PHASE2
NCT05139004 90Y-DOTA-anti-CD25 Basiliximab, Fludarabine, Melphalan, and Total Marrow and Lymphoid Irradiation for the Treatment of High-Risk Acute Leukemia or Myelodysplastic Syndrome Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05123352 Investigation of the Gut Microbiota in Acute Myeloid Leukemia Receiving Two Different Induction Therapies Status UNKNOWN Phase N/A
NCT05107856 PRT1419 as Monotherapy or in Combination With Azacitidine or Venetoclax in R/R Myeloid or B-cell Malignancies Status TERMINATED Phase PHASE1
NCT05105152 PLAT-08: A Study Of SC-DARIC33 CAR T Cells In Pediatric And Young Adults With Relapsed Or Refractory CD33+ AML Status RECRUITING Phase PHASE1
NCT05101551 Study of Talazoparib in Combination With Chemotherapy in Relapsed Pediatric AML to Determine Safety and Efficacy Status RECRUITING Phase PHASE1
NCT05079230 Study of Magrolimab Versus Placebo in Combination With Venetoclax and Azacitidine in Participants With Acute Myeloid Leukemia Status TERMINATED Phase PHASE3
NCT05066958 Ex-vivo Primed Memory Donor Lymphocyte Infusion to Boost Anti-viral Immunity After T-cell Depleted HSCT Status UNKNOWN Phase PHASE1/PHASE2
NCT05066165 Study Investigating NTLA-5001 in Subjects With Acute Myeloid Leukemia Status TERMINATED Phase PHASE1/PHASE2